Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
NCT00349180 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 156
Last updated 2009-03-27
Summary
This study is performed to confirm the optimal dose for THR (total hip replacement).
Conditions
- Arthroplasty, Replacement, Hip
Interventions
- DRUG
-
Enoxaparin sodium
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Yoshihiro IKEDA · Sanofi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
Countries
- Japan
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03251482 ·Status: COMPLETED ·Phase: PHASE2
-
Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty
NCT05449327 ·Status: COMPLETED ·Phase: NA
-
Dose-confirmatory Bridging Study in Total Knee Replacement
NCT01206972 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
NCT01184989 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
NCT01884337 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683 ·Status: COMPLETED ·Phase: PHASE3
-
New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery
NCT00074828 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
NCT00423319 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement
NCT01094886 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00331838 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03891524 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Thromboembolic Events in Total Knee Replacement Patients
NCT03393481 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
NCT01203098 ·Status: COMPLETED ·Phase: PHASE2
-
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
NCT00320398 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
NCT02379663 ·Status: COMPLETED ·Phase: PHASE4
-
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
NCT00723216 ·Status: COMPLETED ·Phase: PHASE3
-
BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery
NCT02170701 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA
NCT07140523 ·Status: RECRUITING ·Phase: PHASE2
-
Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
NCT01153698 ·Status: TERMINATED
-
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
NCT00398905 ·Status: COMPLETED ·Phase: PHASE2
-
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
NCT06611319 ·Status: RECRUITING ·Phase: PHASE3
-
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
NCT00332020 ·Status: COMPLETED ·Phase: PHASE3
-
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
NCT00168818 ·Status: COMPLETED ·Phase: PHASE3